Why the study?
Does a multimarker approach improve the prediction of microvascular obstruction in patients with acute STEMI compared to hs-cTnT alone?
Does a multimarker approach improve the prediction of microvascular obstruction in patients with acute STEMI compared to hs-cTnT alone?
Combining multiple biomarkers does not offer incremental value over hs-cTnT alone for predicting microvascular obstruction after STEMI.
Answers are grounded in this paper and cite their sources.
hs-cTnT alone may suffice for MVO prediction after STEMI; leaves open whether multimarker panels add value in prospective validation.
hs-cTnT, CK, hs-CRP, LDH, AST and ALT peak concentrations provided similar prognostic value for the prediction of MVO. The prognostic utility of NT-proBNP was lower. Combining these biomarkers could not further improve predictive utility compared to hs-cTnT alone.
No takes yet. Share an insight, caveat, or question.
Feistritzer et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: